207 related articles for article (PubMed ID: 15498563)
21. Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment.
Burden RE; Snoddy P; Buick RJ; Johnston JA; Walker B; Scott CJ
Mol Cancer Ther; 2008 Mar; 7(3):538-47. PubMed ID: 18347141
[TBL] [Abstract][Full Text] [Related]
22. Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain.
Lenarcic B; Ritonja A; Strukelj B; Turk B; Turk V
J Biol Chem; 1997 May; 272(21):13899-903. PubMed ID: 9153250
[TBL] [Abstract][Full Text] [Related]
23. Discovery of selective and nonpeptidic cathepsin S inhibitors.
Irie O; Ehara T; Iwasaki A; Yokokawa F; Sakaki J; Hirao H; Kanazawa T; Teno N; Horiuchi M; Umemura I; Gunji H; Masuya K; Hitomi Y; Iwasaki G; Nonomura K; Tanabe K; Fukaya H; Kosaka T; Snell CR; Hallett A
Bioorg Med Chem Lett; 2008 Jul; 18(14):3959-62. PubMed ID: 18572405
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of cysteine proteinases responsible for digestive proteolysis in guts of larval western corn rootworm (Diabrotica virgifera) by expression in the yeast Pichia pastoris.
Bown DP; Wilkinson HS; Jongsma MA; Gatehouse JA
Insect Biochem Mol Biol; 2004 Apr; 34(4):305-20. PubMed ID: 15041015
[TBL] [Abstract][Full Text] [Related]
25. Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design.
Ménard R; Therrien C; Lachance P; Sulea T; Qo H; Alvarez-Hernandez AD; Roush WR
Biol Chem; 2001 May; 382(5):839-45. PubMed ID: 11517939
[TBL] [Abstract][Full Text] [Related]
26. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
Alper PB; Liu H; Chatterjee AK; Nguyen KT; Tully DC; Tumanut C; Li J; Harris JL; Tuntland T; Chang J; Gordon P; Hollenbeck T; Karanewsky DS
Bioorg Med Chem Lett; 2006 Mar; 16(6):1486-90. PubMed ID: 16412634
[TBL] [Abstract][Full Text] [Related]
27. Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K.
Marquis RW; Ru Y; Yamashita DS; Oh HJ; Yen J; Thompson SK; Carr TJ; Levy MA; Tomaszek TA; Ijames CF; Smith WW; Zhao B; Janson CA; Abdel-Meguid SS; D'Alessio KJ; McQueney MS; Veber DF
Bioorg Med Chem; 1999 Apr; 7(4):581-8. PubMed ID: 10353637
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of cathepsin L-like cysteine proteases by cytotoxic T-lymphocyte antigen-2 beta.
Delaria K; Fiorentino L; Wallace L; Tamburini P; Brownell E; Muller D
J Biol Chem; 1994 Oct; 269(40):25172-7. PubMed ID: 7929206
[TBL] [Abstract][Full Text] [Related]
29. Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin.
Schaschke N; Deluca D; Assfalg-Machleidt I; Höhneke C; Sommerhoff CP; Machleidt W
Biol Chem; 2002 May; 383(5):849-52. PubMed ID: 12108551
[TBL] [Abstract][Full Text] [Related]
30. The S2 subsites of cathepsins K and L and their contribution to collagen degradation.
Lecaille F; Chowdhury S; Purisima E; Brömme D; Lalmanach G
Protein Sci; 2007 Apr; 16(4):662-70. PubMed ID: 17384231
[TBL] [Abstract][Full Text] [Related]
31. Acyclic cyanamide-based inhibitors of cathepsin K.
Barrett DG; Deaton DN; Hassell AM; McFadyen RB; Miller AB; Miller LR; Payne JA; Shewchuk LM; Willard DH; Wright LL
Bioorg Med Chem Lett; 2005 Jun; 15(12):3039-43. PubMed ID: 15896958
[TBL] [Abstract][Full Text] [Related]
32. The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition.
Hwang SR; Stoka V; Turk V; Hook VY
Biochemistry; 2005 May; 44(21):7757-67. PubMed ID: 15909990
[TBL] [Abstract][Full Text] [Related]
33. Effects of YM-51084 and YM-51085, new inhibitors produced by Streptomyces sp. Q21705, on cathepsin L.
Teramura K; Orita M; Matsumoto H; Yasumuro K; Abe K
J Enzyme Inhib; 1996 Oct; 11(2):115-21. PubMed ID: 9204400
[TBL] [Abstract][Full Text] [Related]
34. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
Azaryan AV; Hook VY
Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
[TBL] [Abstract][Full Text] [Related]
35. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
[TBL] [Abstract][Full Text] [Related]
36. Rat epidermal cathepsin L-like proteinase: purification and some hydrolytic properties toward filaggrin and synthetic substrates.
Kawada A; Hara K; Hiruma M; Noguchi H; Ishibashi A
J Biochem; 1995 Aug; 118(2):332-7. PubMed ID: 8543567
[TBL] [Abstract][Full Text] [Related]
37. Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.
Portaro FC; Santos AB; Cezari MH; Juliano MA; Juliano L; Carmona E
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):123-9. PubMed ID: 10727410
[TBL] [Abstract][Full Text] [Related]
38. The p41 fragment story.
Turk D; Guncar G; Turk V
IUBMB Life; 1999 Jul; 48(1):7-12. PubMed ID: 10791909
[TBL] [Abstract][Full Text] [Related]
39. Structural requirements for cathepsin B and cathepsin H inhibition by kininogens.
Bano B; Kunapuli SP; Bradford HN; Colman RW
J Protein Chem; 1996 Aug; 15(6):519-25. PubMed ID: 8895098
[TBL] [Abstract][Full Text] [Related]
40. Azepanone-based inhibitors of human cathepsin L.
Marquis RW; James I; Zeng J; Trout RE; Thompson S; Rahman A; Yamashita DS; Xie R; Ru Y; Gress CJ; Blake S; Lark MA; Hwang SM; Tomaszek T; Offen P; Head MS; Cummings MD; Veber DF
J Med Chem; 2005 Nov; 48(22):6870-8. PubMed ID: 16250645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
